Vyxeos: The First Chemotherapy Approved for Adults with Newly-Diagnosed t-AML or AML-MRC
Speakers:
Sandra Kurtin, PhDc, RN, ANP-C, AOCN
University of Arizona
Maria Hanik, DNP, APRN-BC, OCN, BMTCN
Northside Hospital
The asset you are trying to access is locked. Please enter your access key to unlock.